Kolexia
Chabannon Christian
Oncologie médicale
Centre Paoli-Calmettes
Marseille, France
1.1 K Activités
914 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie du greffon contre l'hôte Lymphomes Leucémies Tumeurs hématologiques Leucémie aigüe myéloïde Maladie de Hodgkin Myélome multiple Leucémie myéloïde COVID-19

Industries

Novartis
6 collaboration(s)
Dernière en 2023
Gilead
5 collaboration(s)
Dernière en 2023
BMS
2 collaboration(s)
Dernière en 2023
Edimark
2 collaboration(s)
Dernière en 2020

Dernières activités

Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT).
Cytotherapy   17 février 2024
Current strategies of cell and gene therapy for solid tumors: results of the joint international ESMO and CTIWP-EBMT survey.
Annals of oncology : official journal of the European Society for Medical Oncology   23 décembre 2023
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome.
Bone marrow transplantation   03 novembre 2023
Interindividual HLA Evolutionary Divergence in Single HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation for Malignant Hematological Disorders: A Report on Behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT
65th ASH Annual Meeting Abstracts   02 novembre 2023
Christian Chabannon | Videos & Research | VJHemOnc
VJ HEMONC   21 octobre 2023
Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party.
Frontiers in immunology   27 septembre 2023
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations.
Blood   08 septembre 2023
Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP).
Bone marrow transplantation   06 septembre 2023
GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation.
Bone marrow transplantation   09 août 2023
The European Society for Blood and Marrow Transplantation (EBMT) roadmap and perspectives to improve nutritional care in patients undergoing hematopoietic stem cell transplantation on behalf of the Cellular Therapy and Immunobiology Working Party (CTIWP) and the Nurses Group (NG) of the EBMT.
Bone marrow transplantation   05 juillet 2023